EUVIMEDEUVIMED entdecken
Crossref

Uncovering the anti-inflammatory mechanisms of compound Muniziqi granule against psoriasis by network analysis and experimental evaluation in vivo

Cuiying Fu, Juexi Yang, Xiner Lin, Pu Chen, Yan Dai, Yan Sun, Xiaoke Dou, Yan Wu, Song Zhang

Pathology - Research and Practice · 2026

DOI: 10.1016/j.prp.2026.156484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2026. Verfasst von Cuiying Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Institute o…. Hauptthemen laut MEDLINE: Psoriasis, Anti-Inflammatory Agents, Drugs, Chinese Herbal, Skin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Major Science and Technology Projects of China, National Science and Technology Major Project, Hubei Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the efficacy of Compound Muniziqi Granule (MNZQ) and explore its mechanisms in an imiquimod (IMQ)-induced psoriasiform mouse model. METHODS: IMQ cream was applied to dorsal skin to induce lesions. Treatment groups received MNZQ by oral gavage at 1.8, 3.6, and 5.4 g/kg/day, or methotrexate (MTX, 10 mg/kg/week). MNZQ was chemically characterized by UPLC-MS/MS to profile its metabolites. The curated metabolite set was then used for network analysis and molecular docking. Predicted targets and pathways were evaluated by in vivo outcomes (PASI scores and H&E histology) and bench validation, including RT-qPCR (Il17a/Il22), flow cytometry (Th17, γδ T17), and Western blotting for STAT3, AKT, mTOR, and their phosphorylated forms. RESULTS: MNZQ significantly improved clinical and histological indices. As a hypothesis-generating step, in silico network analysis and molecular docking prioritized Th17 differentiation and the IL-17, JAK-STAT, and PI3K-AKT pathways. Consistent with these predictions, MNZQ was associated with lower frequencies of Th17 and γδ T17 cells in skin, spleen, and draining lymph nodes, and with reduced Il17a/Il22 transcripts in lesions and draining nodes (no clear dose-response). At the protein level, lesional skin showed decreased phosphorylation of STAT3, AKT, and mTOR. CONCLUSION: The findings indicate that MNZQ exerts anti-psoriatic efficacy in vivo, concurrent with decreases in γδ T17/Th17 cells frequencies and attenuation of the pro-inflammatory JAK-STAT3 and PI3K-AKT-mTOR signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisAnti-Inflammatory AgentsDrugs, Chinese HerbalSkinAnimalsMiceSignal TransductionTh17 CellsDisease Models, AnimalMolecular Docking SimulationImiquimodSTAT3 Transcription FactorFemale

Stichwörter der Autor:innen

Compound Muniziqi granuleJAK-STAT3Network analysisPI3K-AKT-mTORPsoriasisTh17 cell differentiation

Substanzen

Anti-Inflammatory AgentsDrugs, Chinese HerbalImiquimodSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medica…
  • Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, China.
  • Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1277, Jiefang Avenue, Wuhan 430022, China. Electronic address: wuyan5151@hust.edu.cn.
  • Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1277, Jiefang Avenue, Wuhan 430022, China. Electronic address: zhangsong767@163.com.

Förderung

  • National Major Science and Technology Projects of China
  • National Science and Technology Major Project
  • Hubei Province Natural Science Foundation

Zitieren

APA

Fu, C., Yang, J., Lin, X., Chen, P., Dai, Y., Sun, Y., Dou, X., Wu, Y., & Zhang, S. (2026). Uncovering the anti-inflammatory mechanisms of compound Muniziqi granule against psoriasis by network analysis and experimental evaluation in vivo. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2026.156484

Vancouver

Fu C, Yang J, Lin X, Chen P, Dai Y, Sun Y, et al. Uncovering the anti-inflammatory mechanisms of compound Muniziqi granule against psoriasis by network analysis and experimental evaluation in vivo. Pathology - Research and Practice. 2026. doi:10.1016/j.prp.2026.156484

BibTeX
@article{Fu2026,
  author = {Fu, Cuiying and Yang, Juexi and Lin, Xiner and Chen, Pu and Dai, Yan and Sun, Yan and Dou, Xiaoke and Wu, Yan and Zhang, Song},
  title = {Uncovering the anti-inflammatory mechanisms of compound Muniziqi granule against psoriasis by network analysis and experimental evaluation in vivo},
  journal = {Pathology - Research and Practice},
  year = {2026},
  doi = {10.1016/j.prp.2026.156484}
}
Kostenlos starten →